A proposed federal rule seeks to shift grant funding decisions from independent scientific review panels to political appointees within agencies, raising serious concerns about politicizing science funding.

Massachusetts researchers, officials, and scientific societies oppose the change, arguing it would allow funding denial or cancellation based on perceived alignment with the administration’s priorities or values and undermine scientific merit.

Public-facing commentary emphasizes potential impacts on Americans’ health, safety, and economy as restricted communication, conference participation, and publication opportunities for federally funded researchers could follow.

The policy dispute is high-stakes and galvanizes scientific alarm, with calls for public input to safeguard the integrity of science funding processes.

Prominent voices warn the rule could undermine clinical research quality and stability, delay long-term trials, and create uncertainty that deters investment and slows progress in fields like cancer research and climate science.

The public comment period ends in mid-July, with nearly 300,000 comments submitted and around 51,000 analyzed, about 94 percent of analyzed comments opposing the rule changes.

Massachusetts faces heightened risk due to high NIH funding per capita, with officials citing potential losses in NIH/NSF funding and stalled clinical trials tied to prior funding cuts.

Nobel laureates and leading scientific associations warn politicizing grant decisions would harm foundational science, public health, and safety.

Universities and scientific organizations urge public comments during the open period, while supporters tout transparency and accountability and opponents fear political manipulation of science.

The rule could restrict international collaboration, conference participation, and public science communication, and could even threaten funding for projects tied to diversity or perceived woke agendas, heightening chilling effects across disciplines.

Many scientists argue funding should be guided by peer-reviewed merit, not political litmus tests, to preserve exploratory and high-risk research.

Potential consequences include reduced leadership in fundamental science and adverse effects on areas like quantum research, weather forecasting, disaster response, and cancer funding.